Effects of changes in prenatal aneuploidy screening policies in an integrated health care system

Obstetrics and Gynecology

Volumn 121, Issue 2 PART 1, 2013, Pages 265-271

  Norton, Mary E ^a,b,c   Nakagawa, Sanae ^a,b,c   Norem, Carol ^a,b,c   Gregorich, Steven E ^a,b,c   Kuppermann, Miriam ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Kaiser Permanente Northern California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; BIRTH; CHROMOSOME ABERRATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC TEST; FEMALE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; PRENATAL SCREENING; PRIORITY JOURNAL;

ADULT; ANEUPLOIDY; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; UNITED STATES;

EID: 84873802048     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31827e5c85     Document Type: Conference Paper

References (18)

1. Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin. No. 77. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:217-27.
2. Invasive prenatal testing for aneuploidy. ACOG Practice Bulletin No. 88, December 2007. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:1459-67.
3. Wasden SW, Adams BN, Chasen ST. Are age cutoffs still used to identify candidates for invasive testing for chromosomal abnormalities? J Reprod Med 2011;56:113-6.
4. Nakata N, Wang Y, Bhatt S. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn 2010;30:198-206.
5. Benn PA, Egan JFX, Fan M, Smith-Bindman R. Changes in the utilization of prenatal diagnosis. Obstet Gynecol 2004;103: 1255-60.
6. Benn PA, Fan M, Egan JFX. Trends in the use of second trimester maternal serum screening from 1991 to 2003. Genet Med 2005;7:328-31.
7. Wray AM, Ghidini A, Alvis C, Hodor J, Landy HJ, Poggi SH. The impact of first-trimester screening on AMA patients' uptake of invasive testing. Prenat Diagn 2005;25:350-3.
8. Druzin ML, Chervenak F, McCullough LB, Blatman RN, Neidich JA. Should all pregnant patients be offered prenatal diagnosis regardless of age? Obstet Gynecol 1993;81:615-8.
9. Prospective screening for Down syndrome using maternal serum AFP. Lancet 1985;1:1280-1.
10. Driscoll DA, Morgan MA, Schulkin J. Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 2009:459.e1-9.
11. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
12. Bianchi DW, Platt LK, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP;MatErnal Blood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
13. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
14. Chen EZ, Chiu RWK, Sun H, Akolekar R. Non-invasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6:e21791.
15. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:319.e1-9.
16. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:322.e1-5.
17. NortonME, Brar H,Weiss J, Karimi A, Laurent LC, Caughey AB, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207: 137.e1-8.
18. Kuppermann M, Learman LA, Gates E, Gregorich SE, Nease RF Jr, Lewis J, et al. Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol 2006;107:1087-97.